5//SEC Filing
Rozenman Mary M. 5
Accession 0000899243-20-004694
CIK 0001631650other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:23 PM ET
Size
5.9 KB
Accession
0000899243-20-004694
Insider Transaction Report
Form 5
Rozenman Mary M.
See Remarks
Transactions
- Tax Payment
Common Stock, $0.0001 par value
2019-03-01$24.30/sh−626$15,213→ 13,878 total
Footnotes (3)
- [F1]The reported sale was made pursuant to a pre-determined election to sell shares to cover tax withholding obligations in connection with the vesting of a previously reported equity award.
- [F2]Includes 6,249 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F3]Includes 7,500 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001648920
Filing Metadata
- Form type
- 5
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:23 PM ET
- Size
- 5.9 KB